Hospira, Inc.

Date: 05/04/2021

Product Description

0.5% Bupivacaine Hydrochloride Injection, USP 30 mL and 1% Lidocaine HCl Injection, USP 30 mL

Recall Reason Description

Due to mislabeling

Company Name

Hospira, Inc.

US FDA Link: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/hospira-issues-voluntary-nationwide-recall-one-lot-05-bupivacaine-hydrochloride-injection-usp-and